JP2000511411A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511411A5
JP2000511411A5 JP1997539170A JP53917097A JP2000511411A5 JP 2000511411 A5 JP2000511411 A5 JP 2000511411A5 JP 1997539170 A JP1997539170 A JP 1997539170A JP 53917097 A JP53917097 A JP 53917097A JP 2000511411 A5 JP2000511411 A5 JP 2000511411A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997539170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007198 external-priority patent/WO1997041151A2/en
Publication of JP2000511411A publication Critical patent/JP2000511411A/ja
Publication of JP2000511411A5 publication Critical patent/JP2000511411A5/ja
Pending legal-status Critical Current

Links

JP09539170A 1996-05-01 1997-05-01 抗―肺炎球菌ワクチン用のコリン結合タンパク質 Pending JP2000511411A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1663296P 1996-05-01 1996-05-01
US64225096A 1996-05-01 1996-05-01
US60/016,632 1996-05-01
US08/642,250 1996-05-01
PCT/US1997/007198 WO1997041151A2 (en) 1996-05-01 1997-05-01 Choline binding proteins for anti-pneumococcal vaccines

Publications (2)

Publication Number Publication Date
JP2000511411A JP2000511411A (ja) 2000-09-05
JP2000511411A5 true JP2000511411A5 (enExample) 2005-01-13

Family

ID=26688869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09539170A Pending JP2000511411A (ja) 1996-05-01 1997-05-01 抗―肺炎球菌ワクチン用のコリン結合タンパク質

Country Status (8)

Country Link
EP (1) EP0912608B1 (enExample)
JP (1) JP2000511411A (enExample)
AT (1) ATE323721T1 (enExample)
AU (1) AU732520B2 (enExample)
CA (1) CA2253252A1 (enExample)
DE (1) DE69735715T2 (enExample)
ES (1) ES2262177T3 (enExample)
WO (1) WO1997041151A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
AU5355398A (en) * 1996-11-12 1998-06-03 Regents Of The University Of Minnesota C3 binding protein of (streptococcus pneumoniae)
DE19708537A1 (de) * 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
NZ530277A (en) * 1998-04-07 2005-08-26 Medimmune Inc Derivatives of pneumococcal choline binding proteins for vaccines
AU2004200125B2 (en) * 1998-04-07 2006-07-27 Med Immune, Inc. Derivatives of Pneumococcal Choline Binding Proteins for Vaccines
AU3479699A (en) * 1998-04-07 1999-10-25 St. Jude Children's Research Hospital A polypeptide comprising the amino acid of an n-terminal choline binding proteina truncate, vaccine derived therefrom and uses thereof
US6858706B2 (en) 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
AU2027400A (en) * 1998-11-19 2000-06-05 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding proteins, cbpg and cbpd, and diagnostic and therapeutic uses thereof
US6495139B2 (en) 1998-11-19 2002-12-17 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
CA2355364C (en) 1998-12-21 2014-03-18 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
CA2366152A1 (en) 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Streptococcus pneumoniae vaccine
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
CA2503871C (en) 2002-11-01 2012-12-11 Glaxosmithkline Biologicals S.A. An immunogenic composition for generating an immune response against polio virus
AU2004277342B2 (en) 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
JP5792920B2 (ja) 2005-12-22 2015-10-14 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
MX2008009280A (es) 2006-01-17 2008-12-12 Arne Forsgren Una nueva proteina de haemophilus influenzae expuesta en la superficie (proteina e; pe).
EA200901578A1 (ru) 2007-06-26 2010-08-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
KR20110009157A (ko) 2008-04-16 2011-01-27 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
WO2010126146A1 (ja) * 2009-04-30 2010-11-04 Tanaka Noriaki 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
EP2544714A1 (en) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Vaccine composition
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
KR20140033127A (ko) 2011-05-17 2014-03-17 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애에 대한 백신
US11207396B2 (en) 2013-05-17 2021-12-28 The Board Of Regents Of The University Of Texas System Immunization to protect against adverse cardiac events relating to pneumococcal infection
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201711635D0 (en) 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
CN115335504A (zh) * 2019-11-18 2022-11-11 Vaxcyte公司 链球菌的无动物产物培养

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4400293A (en) * 1992-05-29 1993-12-30 Janet Yother Methods for obtaining and purifying cell-free pneumococcal surface proteins from (s. pneumoniae) and use thereof
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
CZ394297A3 (cs) * 1995-06-07 1998-04-15 Biochem Vaccines Inc. Streptokokové proteiny teplotního šoku ze skupiny HSP70

Similar Documents

Publication Publication Date Title
JP2000506994A5 (enExample)
JP2000505328A5 (enExample)
JP2000506726A5 (enExample)
JP2000507844A5 (enExample)
JP2000505609A5 (enExample)
JP2000500076A5 (enExample)
JP2000506275A5 (enExample)
JP2000509299A5 (enExample)
JP2000510894A5 (enExample)
JP2000503163A5 (enExample)
JP2000507909A5 (enExample)
JP2000513715A5 (enExample)
JP2001504009A5 (enExample)
JP2001504900A5 (enExample)
JP2001505550A5 (enExample)
JP2000516830A5 (enExample)
JP2000511355A5 (enExample)
JP2000503249A5 (enExample)
JP2000513709A5 (enExample)
JP2000512184A5 (enExample)
JP2000506333A5 (enExample)
JP2000512134A5 (enExample)
JP2000506624A5 (enExample)
JP2000502570A5 (enExample)
JP2000510509A5 (enExample)